Pulmonary Embolism
Conditions
Keywords
Vena Cava Filter
Brief summary
Migration of a thrombus in the pulmonary circulation is the leading cause of pulmonary embolism (PE). It can be prevented mechanically by implanting a vena cava filter (VCF) in the inferior vena cava. The implation of a VCF is indicated for patients with acute PE and a contraindication to anticoagulation, with an acute deep vein thrombosis (DVT) without PE and a contraindication to anticoagulation or with acute venous thromboembolism (less than 3 months) in whom an interventional gesture at hemorrhagic and thromboembolic risk contraindicates anticoagulation. The purpose of this study is to describe the rates of implantation, removal and complications associated with the use of the optional ALN OATF VCF in current practice.
Interventions
DEVICEFilter implantation
Implantation of OATF ALN vena cava filter
Sponsors
Assistance Publique - Hôpitaux de Paris
Aln2b SARL
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient implanted with an ALN OATF VCF * Patient informed
Exclusion criteria
* Minor patient * Adult patient under a legal protection measure * Pregnant, parturient or breastfeeding women * Patient who refused to participate * Patient who cannot or does not wish to be followed by the Interventional Radiology Department
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Filter implantation | day 0 | Rate of technical success of filter implantation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Filter removal | up to 1 year | Rate of filter removal |
Countries
France
Contacts
PRINCIPAL_INVESTIGATOROlivier PELLERIN, MD - PhD
Assistance Publique - Hôpitaux de Paris
Outcome results
None listed